Fig. 1. (A) The neuroprotective effect of SFC on glutamate-induced cytotoxicity in neuronal HT22 cells. (B) The effect of SFC alone in HT22 cells. Each bar represents the mean relative cell viability (%) ± SD of three independent experiments. *p<0.05 and **p<0.01 vs glutamate-injured cells. (C) Morphological phase change of HT 22 cells. a) Control cells; b) Glutamate-treated cells c) SFC (500 μg/ml)-treated cells d) Trolox (positive control)-treated cells.
© Biomolecules & Therapeutics
